True pharma-patient co-creation
A recent MS patient group forum hosted by Merck KGaA demonstrates the power of true co-creation with patients.
This year saw Merck KGaA host its third patient group forum at the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) congress in Sweden.
But this forum had a key difference from previous years – it was developed entirely in collaboration with multiple sclerosis (MS) patient advocate Trishna Bharadia.
Bharadia says that this affected every aspect of the forum’s design, and resulted in a resounding success that Merck hopes to replicate in the future.